All Stories

  1. Addressing the Burden and Management Strategies for Disparities and Inequities Among Liver Transplant Professionals: The ILTS Experience
  2. P10 Living donor liver transplantation in patients with portal vein thrombosis grade I, II and III: a single center comparative study
  3. Ascites post-living donor liver transplantation: Risk factors and outcome
  4. Risk factors and management of biliary stones after living donor liver transplant and its effect on graft outcome
  5. Outcome of living donor liver transplantation in patients with preoperative portal vein thrombosis
  6. Donor gender effect on graft function in adult Egyptian patients undergoing living donor liver transplantation: A single centre study
  7. Role of inflammatory markers in predicting hepatocellular carcinoma recurrence after liver transplantation
  8. Outcome of Colonoscopic Screening in Potential Liver Transplant Candidates
  9. Long non‐coding RNAs (CASC2 and TUG1) in hepatocellular carcinoma: Clinical significance
  10. SERUM CYSTATIN C AS A BIOMARKER OF KIDNEY DYSFUNCTION IN PATIENTS WITH ADVANCED CIRRHOSIS
  11. Outcome of colonoscopic screening in potential liver transplant candidates
  12. PTU-008 Interleukin 23 as a non-invasive test of disease severity in patients with ulcerative colitis
  13. Outcome of transarterial chemoembolization in Egyptian patients with hepatocellular carcinoma and branch portal vein thrombosis
  14. Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt
  15. Role of microRNA-7 and selenoprotein P in hepatocellular carcinoma
  16. Bacterial infections post-living-donor liver transplantation in Egyptian hepatitis C virus-cirrhotic patients: A single-center study
  17. Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients
  18. Human leukocyte antigen matching in living donor liver transplantation: does it affects the outcome?
  19. Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma
  20. Living donor liver transplantation for high model for end-stage liver disease score: What have we learned?
  21. Effect of living donor liver transplantation on depressive symptoms in hepatitis C virus patients
  22. Value of Cerebrospinal Fluid Tumor Necrosis Factor-Alpha ( TNF-Alpha ) for Rapid Diagnosis of Bacterial Meningitis
  23. Assessment of health-related quality of life in Egyptian HCV-infected recipients after living donor liver transplantation
  24. Changing the face of fever of unknown origin in Egypt: a single hospital study
  25. Role of procalcitonin in diagnosis of bacterial infection in trans-arterial chemoembolisation treated hepatocellular carcinoma patients
  26. Prospective Assessment of the Rockall Risk Scoring System in Egyptian Patients with Upper Gastrointestinal Bleeding
  27. Risk factors for early intrahepatic distant recurrence after radiofrequency ablation for hepatocellular carcinoma in Egyptian patients
  28. Evaluation of Salivary and Serum Anti-Helicobacter Pylori in Egyptian Patients with H. Pylori Related Gastric Disorders
  29. Donor Rejection Before Living Donor Liver Transplantation: Causes and Cost Effective Analysis in an Egyptian Transplant Center.